Abstract
Regulation of gene expression is an important aspect of insulin action but in vivo is intertwined with changing levels of glucose and counter-regulatory hormones. Here we demonstrate that under euglycemic clamp conditions, physiological levels of insulin regulate interrelated networks of more than 1,000 transcripts in muscle and liver. These include expected pathways related to glucose and lipid utilization, mitochondrial function, and autophagy, as well as unexpected pathways, such as chromatin remodeling, mRNA splicing, and Notch signaling. These acutely regulated pathways extend beyond those dysregulated in mice with chronic insulin deficiency or insulin resistance and involve a broad network of transcription factors. More than 150 non-coding RNAs were regulated by insulin, many of which also responded to fasting and refeeding. Pathway analysis and RNAi knockdown revealed a role for lncRNA Gm15441 in regulating fatty acid oxidation in hepatocytes. Altogether, these changes in coding and non-coding RNAs provide an integrated transcriptional network underlying the complexity of insulin action.
Original language | English |
---|---|
Pages (from-to) | 3429-3443.e3 |
Journal | Cell Reports |
Volume | 26 |
Issue number | 12 |
DOIs | |
State | Published - Mar 19 2019 |
Bibliographical note
Publisher Copyright:© 2019 The Author(s)
Funding
This work was supported by NIH grants R37DK031036, R01DK033201 (to C.R.K.), P30DK036836 (to Joslin Diabetes Center), and 5U2C-DK093000 (to J.K.K.) and the Mary K. Iacocca Professorship (to C.R.K.). T.M.B. was partially supported by a grant from Sao Paulo Research Foundation (2014/25370-8). R.G.M. was supported by a Deutsche Forschungsgemeinschaft (DFG) fellowship (GA 2426/1-1). B.T.O. was funded by a K08 training award (K08DK100543) and an R03 award (R03DK112003) from the NIDDK of the NIH. We thank Jonathan M. Dreyfuss and Hui Pan from Joslin Diabetes Center DRC Genomics and Bioinformatics Core for assistance with data analysis. This work was supported by NIH grants R37DK031036 , R01DK033201 (to C.R.K.), P30DK036836 (to Joslin Diabetes Center), and 5U2C-DK093000 (to J.K.K.) and the Mary K. Iacocca Professorship (to C.R.K.). T.M.B. was partially supported by a grant from Sao Paulo Research Foundation ( 2014/25370-8 ). R.G.M. was supported by a Deutsche Forschungsgemeinschaft (DFG) fellowship ( GA 2426/1-1 ). B.T.O. was funded by a K08 training award ( K08DK100543 ) and an R03 award ( R03DK112003 ) from the NIDDK of the NIH . We thank Jonathan M. Dreyfuss and Hui Pan from Joslin Diabetes Center DRC Genomics and Bioinformatics Core for assistance with data analysis.
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | 5U2C-DK093000 |
National Institutes of Health (NIH) | |
National Institute of Diabetes and Digestive and Kidney Diseases | K08DK100543, P30DK036836, R01DK031036, R03DK112003, R01DK033201 |
National Institute of Diabetes and Digestive and Kidney Diseases | |
Joslin Diabetes Center | |
Deutsche Forschungsgemeinschaft | GA 2426/1-1 |
Deutsche Forschungsgemeinschaft | |
Fundação de Amparo à Pesquisa do Estado de São Paulo | 2014/25370-8 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | |
Norges Idrettshøgskole |
Keywords
- diabetes
- fatty acid oxidation
- gene expression
- insulin action
- liver
- mitochondria
- non-coding RNAs
- skeletal muscle
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology